Literature DB >> 10070313

Soft tissue sarcoma after treatment for breast cancer--a Swedish population-based study.

P Karlsson1, E Holmberg, A Samuelsson, K A Johansson, A Wallgren.   

Abstract

The aim was to quantify the risk of post-treatment sarcoma in breast cancer patients. All 122,991 women with a breast cancer from 1958 to 1992 in the Swedish Cancer Register were followed up for soft tissue sarcomas and 116 were found, giving a standardised incidence ratio of 1.9 (95% CI 1.5-2.2). The absolute risk was 1.3 per 10(4) person-years. The sarcomas were located in the breast region or on the ipsilateral arm in 63% (67/106). There were 40 angiosarcomas and 76 sarcomas of other types. In a case-control study, angiosarcoma correlated significantly with lymphoedema of the arm, odds ratio (OR) 9.5 (95% CI 3.2-28.0), but no correlation with radiotherapy was observed. For other types of sarcoma there was a correlation with the integral dose. The dose-response relationship indicated that the risk increased linearly with the integral dose to 150-200 J and stabilised at higher energies. The OR was 2.4 (95% CI 1.4-4.2) for an energy of 50 J, approximately corresponding to the radiation of the breast after breast-conserving surgery. Thus, only oedema of the arm correlated with angiosarcoma, but for other types of sarcoma the integral dose of radiotherapy was a predictor of the risk.

Entities:  

Mesh:

Year:  1998        PMID: 10070313     DOI: 10.1016/s0959-8049(98)00319-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  31 in total

1.  Malignant fibrous histiocytoma of the urinary bladder as a post-radiation secondary cancer: a case report.

Authors:  Thirayost Nimmanon; Poonkiat Ruengpoka
Journal:  J Med Case Rep       Date:  2011-11-10

Review 2.  Secondary malignancies across the age spectrum.

Authors:  Andrea K Ng; Lisa B Kenney; Ethel S Gilbert; Lois B Travis
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

3.  Follicular dendritic cell sarcoma presenting as a painless lump in the parotid.

Authors:  Emma McClelland; Anthony Bashyam; Stephen Derbyshire; Silvana Di Palma
Journal:  BMJ Case Rep       Date:  2018-05-30

Review 4.  Radiation-induced malignant fibrous histiocytoma of the maxilla.

Authors:  Takafumi Satomi; Masato Watanabe; Tadayoshi Kaneko; Jun Matsubayashi; Toshitaka Nagao; Hiroshige Chiba
Journal:  Odontology       Date:  2011-04-13       Impact factor: 2.634

Review 5.  [Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].

Authors:  Carolin Nestle-Krämling; Edwin Bölke; Wilfried Budach; Matthias Peiper; Dieter Niederacher; Wolfgang Janni; Claus Ferdinand Eisenberger; Wolfram Trudo Knoefel; Axel Scherer; Stephan Ernst Baldus; Guido Lammering; Peter Arne Gerber; Christiane Matuschek
Journal:  Strahlenther Onkol       Date:  2011-08-16       Impact factor: 3.621

6.  Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema.

Authors:  S R Harris; M R Hugi; I A Olivotto; M Levine
Journal:  CMAJ       Date:  2001-01-23       Impact factor: 8.262

7.  Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition.

Authors:  Emma C Starritt; David Joseph; J Gregory McKinnon; Sing Kai Lo; Johannes H W de Wilt; John F Thompson
Journal:  Ann Surg       Date:  2004-11       Impact factor: 12.969

Review 8.  A guide to oncological management of soft tissue tumours of the abdominal wall.

Authors:  K J Williams; A J Hayes
Journal:  Hernia       Date:  2013-09-17       Impact factor: 4.739

9.  Radiation-induced sarcoma of the breast: a systematic review.

Authors:  Grishma R Sheth; Lee D Cranmer; Benjamin D Smith; Lauren Grasso-Lebeau; Julie E Lang
Journal:  Oncologist       Date:  2012-02-14

Review 10.  Prostate angiosarcoma: is there any association with previous radiation therapy?

Authors:  Waseem Khaliq; Christian F Meyer; Ikechukwu Uzoaru; Richard M Wolf; Emmanuel S Antonarakis
Journal:  BJU Int       Date:  2012-05-15       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.